A Phase 3 clinical study of Samuraciclib
Latest Information Update: 22 May 2025
At a glance
- Drugs Samuraciclib (Primary)
- Indications Breast cancer; Solid tumours
- Focus Registrational; Therapeutic Use
Most Recent Events
- 22 May 2025 New trial record
- 15 May 2025 According to a Carrick Therapeutics media release, company shows intention to advance to Phase 3 in 2026, enriching for one of these two patient groups.